As of Jul 17
| +0.26 / +1.31%|
The 6 analysts offering 12-month price forecasts for Nightstar Therapeutics PLC have a median target of 27.50, with a high estimate of 40.00 and a low estimate of 20.00. The median estimate represents a +36.68% increase from the last price of 20.12.
The current consensus among 6 polled investment analysts is to Buy stock in Nightstar Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.